Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment

被引：0
|
作者：
Toshiyuki Iwahori
机构：
[1] Eli Lilly Japan K.K.,Medicines Development Unit Japan and Medical Affairs
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2441 / 2442
页数：1
相关论文
共 50 条
  • [21] GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus
    Dahiya, Lalita
    Kaur, Ramandeep
    Kumar, Rajiv
    Kumar, Manoj
    Palta, Kezia
    [J]. CURRENT DIABETES REVIEWS, 2020, 16 (04) : 279 - 292
  • [22] Exenatide, a GLP-1 agonist in the treatment of Type 2 diabetes
    Sennik, Devesh
    Ahmed, Fahad
    Russell-Jones, David
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2012, 7 (01) : 15 - 26
  • [23] GLP-1 receptor agonist on cardiovascular complications of diabetes mellitus
    Liu, Fengjun
    Kong, Yanhua
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (03) : 2259 - 2265
  • [24] PATIENTS' PREFERENCES IN ORAL DIABETES TREATMENT: A DISCRETE CHOICE EXPERIMENT IN TYPE2 DIABETES MELLITUS
    Muehlbacher, A. C.
    Bethge, S.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A355 - A355
  • [25] Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
    Kristina S. Boye
    Dara Stein
    Louis S. Matza
    Jessica Jordan
    Ren Yu
    Kirsi Norrbacka
    Syed Wasi Hassan
    Luis-Emilio García-Pérez
    [J]. Drugs in R&D, 2019, 19 : 213 - 225
  • [26] Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
    Boye, Kristina S.
    Stein, Dara
    Matza, Louis S.
    Jordan, Jessica
    Yu, Ren
    Norrbacka, Kirsi
    Hassan, Syed Wasi
    Garcia-Perez, Luis-Emilio
    [J]. DRUGS IN R&D, 2019, 19 (02) : 213 - 225
  • [27] Dulaglutide: A GLP-1 Receptor Agonist for Once Weekly Treatment of Type 2 Diabetes
    Heitmann, E.
    Jung, H.
    Schloot, N.
    Pavo, I.
    Forst, T.
    Trautmann, M.
    Schernthaner, G.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2016, 11 (06) : 398 - 417
  • [28] Liraglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity
    Gallwitz, B.
    [J]. DRUGS OF THE FUTURE, 2008, 33 (01) : 13 - 20
  • [29] Oral Semaglutide: First-in-Class Oral GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus
    Cowart, Kevin
    [J]. ANNALS OF PHARMACOTHERAPY, 2020, 54 (05) : 478 - 485
  • [30] Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review
    Ostergaard, L.
    Frandsen, Christian S.
    Madsbad, S.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (02) : 241 - 265
12345